132 related articles for article (PubMed ID: 23031753)
1. Buruli ulcer in a nine-month-old boy.
Tsukagoshi S; Dehn TC
Ann R Coll Surg Engl; 2012 Oct; 94(7):e215-6. PubMed ID: 23031753
[TBL] [Abstract][Full Text] [Related]
2. Buruli ulcer. A disabling infection.
Prescrire Int; 2010 Nov; 19(110):261-2. PubMed ID: 21284361
[TBL] [Abstract][Full Text] [Related]
3. [A Papua New Guinean with three foot ulcers].
Coenders A; Verregghen M; Baerends EP
Ned Tijdschr Geneeskd; 2018; 162():D2295. PubMed ID: 29372678
[TBL] [Abstract][Full Text] [Related]
4. Short report: edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: a case report.
Phanzu DM; Ablordey A; Imposo DB; Lefevre L; Mahema RL; Suykerbuyk P; Meyers WM; Portaels F
Am J Trop Med Hyg; 2007 Dec; 77(6):1099-102. PubMed ID: 18165530
[TBL] [Abstract][Full Text] [Related]
5. Buruli ulcer in an 18-day-old baby.
Kiiza AM; Wood PB
Trop Doct; 2012 Jan; 42(1):48. PubMed ID: 22080481
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review.
Tanywe A; Fernandez RS
JBI Database System Rev Implement Rep; 2017 Jan; 15(1):119-139. PubMed ID: 28085731
[TBL] [Abstract][Full Text] [Related]
7. New foci of Buruli ulcer, Angola and Democratic Republic of Congo.
Kibadi K; Panda M; Tamfum JJ; Fraga AG; Longatto Filho A; Anyo G; Pedrosa J; Nakazawa Y; Suykerbuyk P; Meyers WM; Portaels F
Emerg Infect Dis; 2008 Nov; 14(11):1790-2. PubMed ID: 18976574
[TBL] [Abstract][Full Text] [Related]
8. Suspected Buruli ulcer of the face: a case report from Ethiopia.
Gordon D; Zelalem M; Schutze GE; Bilcha K
Pediatr Infect Dis J; 2014 Mar; 33(3):323-5. PubMed ID: 24030348
[TBL] [Abstract][Full Text] [Related]
9. Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
Yotsu RR; Richardson M; Ishii N
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012118. PubMed ID: 30136733
[TBL] [Abstract][Full Text] [Related]
10. Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.
Sopoh GE; Dossou AD; Brun LV; Barogui YT; Houézo JG; Affolabi D; Anagonou SY; Johnson RC; Kestens L; Portaels F
Am J Trop Med Hyg; 2010 Aug; 83(2):307-13. PubMed ID: 20682873
[TBL] [Abstract][Full Text] [Related]
11. [Ghana: the experience in the land highly endemic for Buruli ulcer].
Yotsu R
Nihon Hansenbyo Gakkai Zasshi; 2012 Apr; 81(1-2):155-9. PubMed ID: 22586949
[No Abstract] [Full Text] [Related]
12. Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.
Velink A; Woolley RJ; Phillips RO; Abass KM; van der Werf TS; Agumah E; de Zeeuw J; Klis S; Stienstra Y
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005261. PubMed ID: 28033343
[TBL] [Abstract][Full Text] [Related]
13. Child case of Buruli ulcer successfully treated through a school-based skin survey project in Côte d'Ivoire.
Yotsu RR; Murase C; N'guessan K; Yao A; Kouadio K; N'Golo DC; N'Guetta A; Akiyama M; Constance K; Vagamon B
J Dermatol; 2020 Feb; 47(2):e64-e65. PubMed ID: 31729074
[No Abstract] [Full Text] [Related]
14. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
[TBL] [Abstract][Full Text] [Related]
15. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
Chauty A; Ardant MF; Adeye A; Euverte H; Guédénon A; Johnson C; Aubry J; Nuermberger E; Grosset J
Antimicrob Agents Chemother; 2007 Nov; 51(11):4029-35. PubMed ID: 17526760
[TBL] [Abstract][Full Text] [Related]
16. [Combined local and vaginal therapy in Buruli ulcer].
Milánkovits M
Orv Hetil; 2010 Aug; 151(35):1434-5. PubMed ID: 20824910
[No Abstract] [Full Text] [Related]
17. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
[TBL] [Abstract][Full Text] [Related]
19. To Buruli or not to Buruli.
Ho L; Cohn J; Comte E
Trop Doct; 2013 Apr; 43(2):92. PubMed ID: 23796682
[No Abstract] [Full Text] [Related]
20. Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
Amoussouhoui AS; Sopoh GE; Wadagni AC; Johnson RC; Aoulou P; Agbo IE; Houezo JG; Boyer M; Nichter M
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006291. PubMed ID: 29529087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
